Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 674.95

+3.1%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2919)	4/27/2020 10:10:59 AM
From: Miljenko Zuanic	Read Replies (1) of 3557

So, Kevzara (COVID-19) news (https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-us-phase-23-adaptive) is hot: -Kevzara did not show benefit in standard severe (low oxygenation) COVID-19 pts... -Subcutaneous Kevzara does not stand the chance, <TARRYTOWN, N.Y. and PARIS, April 27, 2020 /PRNewswire/ -- Independent Data Monitoring Committee recommended continuing ongoing Phase 3 trial only in the more advanced "critical" group with Kevzara higher-dose versus placebo and discontinuing less advanced "severe" group Phase 3 trial will be amended to enroll only "critical" patients Phase 3 trial also be amended to discontinue lower-dose Kevzara (200 mg); all new patients to receive either higher-dose Kevzara (400 mg) or placebo No new safety findings were observed for Kevzara use in COVID-19 patients> And Libtayo (1LNSCLC, PDL1 ++) news ( investor.regeneron.com is not hot: -Cemiplimab is comparable (HR 0.68 v 0.60) to Keytruda, as monotherapy versus chemo, in 1L NSCLC PDL1 positive (+50%), <TARRYTOWN, N.Y. and PARIS, April 27, 2020 /PRNewswire/ -- Libtayo decreased the risk of death by 32.4% compared to chemotherapy Regeneron and Sanofi plan regulatory submissions in 2020>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next